ALIA-1758 is under clinical development by Aliada Therapeutics and currently in Phase I for Alzheimer's Disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback